
Plant molecular pharming has emerged as a reliable platform for recombinant protein expression providing a safe and low-cost alternative to bacterial and mammalian cells-based systems. Simultaneously, plant viruses have evolved from pathogens to molecular tools for recombinant protein expression, chimaeric viral vaccine production, and lately, as nanoagents for drug delivery. This review summarizes the genesis of viral vectors and agroinfection, the development of non-enveloped viruses for various biotechnological applications, and the on-going research on enveloped plant viruses.
Plant rhabdoviruses, Virus like particles, recombinant vaccines, Plant culture, Non-enveloped viruses, Plant Science, Plant molecular pharming, non-enveloped viruses, SB1-1110, Recombinant vaccines, virus like particles, plant rhabdoviruses, Biotechnology, plant molecular pharming, biotechnology
Plant rhabdoviruses, Virus like particles, recombinant vaccines, Plant culture, Non-enveloped viruses, Plant Science, Plant molecular pharming, non-enveloped viruses, SB1-1110, Recombinant vaccines, virus like particles, plant rhabdoviruses, Biotechnology, plant molecular pharming, biotechnology
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 42 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
